Indomethacin-responsive headache syndromes

Current Pain and Headache Reports

Volumn 8, Issue 1, 2004, Pages 19-26

  Dodick, David W ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ANTACID AGENT; CAFFEINE; CALCITONIN GENE RELATED PEPTIDE; CARBAMAZEPINE; CORTICOSTEROID DERIVATIVE; CYCLIC AMP; DICLOFENAC; DIHYDROERGOTAMINE; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; LAMOTRIGINE; LITHIUM CARBONATE; METHYSERGIDE; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PHOSPHODIESTERASE; PIROXICAM; PROSTAGLANDIN SYNTHASE; ROFECOXIB; SULINDAC; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VERAPAMIL;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ANALGESIC ACTIVITY; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; APLASTIC ANEMIA; AUTONOMIC NERVE; AUTONOMIC NEUROPATHY; CHIARI FROMMEL SYNDROME; CHOLINERGIC SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER HEADACHE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM ULCER; DISEASE CLASSIFICATION; DIZZINESS; DRUG ABSORPTION; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TISSUE LEVEL; DYSPEPSIA; ENZYME INHIBITION; FATIGUE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HEMICRANIA CONTINUA; HUMAN; HYPNIC HEADACHE; INTRACRANIAL PRESSURE; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MENTAL DISEASE; MIGRAINE; NAUSEA; NEUROLOGIC DISEASE; NEUTROPENIA; NOSE CONGESTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL HEMICRANIA; PATHOPHYSIOLOGY; PRIMARY COUGH HEADACHE; PRIMARY EXERTIONAL HEADACHE; PRIMARY STABBING HEADACHE; PSYCHOSIS; REVIEW; RHINORRHEA; SOMNOLENCE; SUICIDE; TENSION HEADACHE; THROMBOCYTOPENIA; TRIGEMINUS NEURALGIA; VALSALVA MANEUVER; VOMITING; DOSE RESPONSE; HEADACHE AND FACIAL PAIN; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEADACHE DISORDERS; HUMANS; INDOMETHACIN; MIGRAINE DISORDERS; TREATMENT OUTCOME;

EID: 1642633819     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-004-0036-6     Document Type: Review

References (63)

1. Goadsby PJ, Lipton RB: A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997, 120:193-209.
2. Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48-56.
3. Goadsby PJ, Edvinsson L: Human in vivo evidence for trigeminovascular activation in cluster headache: neuropeptide changes and effects of acute attacks therapies. Brain 1994, 117:427-434.
4. Goadsby PJ, Edvinsson L: Neuropeptide changes in a case of chronic paroxysmal hemicrania: evidence for trigemino-parasympathetic activation. Cephalalgia 1996, 16:448-450.
5. May A, Bahra A, Buchel Q et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
6. May A, Bahra A, Buchel C, et al.: Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 1999, 46:787-790.
7. Pascual J, Iglesias F, Oterino A, et al.: Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology 1996, 46:1520-1524.
8. Raskin NH: The cough headache syndrome: treatment. Neurology 1995, 45:1784.
9. Antonacci F, Sjaastad O: Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989, 29:648-656.
10. Boes C, Dodick DW: The clinical spectrum of chronic paroxysmal hemicrania seen at the Mayo Clinic from 1976-1996. Headache 2003, in press.
11. Russell D: Chronic paroxysmal hemicrania: severity, duration, and time of occurrence of attacks. Cephalalgia 1984, 4:53-56.
12. Manzoni GC, Terzano MG, Bono G, et al.: Cluster headache: clinical findings in 180 patients. Cephalalgia 1983, 3:21-30.
13. Newman LC, Lipton RB, Soloman S: Hemicrania continua: ten new cases and a review of the literature. Neurology 1994, 44:2111-2114.
14. Peres MF, Silberstein SD, Nahmias S, et.al.: Hemicrania continua is not that rare: 26 new cases. Neurology 20017:948-951.
15. Perez MF, Siow HC, RozenTD: Hemicrania continua with aura. Neurology 2001, 56(suppl 3):A452.
16. Bordini C, Antonaci F, Stovner LJ, et al.: Hemicrania continua: a clinical review. Headache 1991, 31:20-26.
17. Rooke ED: Benign exertional headache. Med Clin North Am 1968, 52:801-808.
18. Rasmussen BK, Jensen R, Schroll M, et al.: Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991, 44:1147-1157.
19. Headache Classification Committee of the International Headache Society: Classification and Diagnostic Criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8:1-96.
20. Pareja JA, Ruiz J, de Isla C, et al,: Idiopathic stabbing headache. Cephalalgia 1996, 16:93-96.
21. Raskin NL: The hypnic headache syndrome. Headache 1988, 28:534-536.
22. Dodick DW, Mosek A, Campbell JK: The hypnic ("alarm clock") headache syndrome. Cephalalgia 1998, 18:152-156.
23. Dodick DW: Hypnic headache: another indomethacin-responsive headache syndrome? Headache 2000, 40:830-835.
24. Pareja JA, Sjaastad O: SUNCT syndrome: a clinical review. Headache 1997, 37:195-202.
25. D'Andrea G, Granella F, Cadaldini M: Possible usefulness of lamotrigine in the treatment of SUNCT syndrome. Neurology 1999, 53:1609.
26. Graff-Radford SB: SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 2000, 20:515-517.
27. Pareja JA, Sjaastad O: Chronic paroxysmal hemicrania and hemicrania continua: interval between indomethacin administration and response. Headache 1996, 36:20-23.
28. Sanchez del Rio M, Caminero AB, Pascual J, et al.: Dose and efficacy of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001, 21:507.
29. Kuritzky A: Indomethacin-resistant hemicrania continua. Cephalalgia 1992, 12:57-59.
30. Sjaastad O, Stovner LJ, Stolt-Nielsen A, et al.: CPH and hemicrania continua: requirements of high indomethacin dosages. An ominous sign? Headache 1995, 35:363-367.
31. Eross EJ, Swanson JW: Hemicrania continua: an indomethacin-responsive case with an underlying malignant etiology. Neurology 2001, 56(suppl 3):A452.
32. Antonaci F, Sjaastad O: Hemicrania continua: a possible symptomatic case, due to mesenchymal tumor. Funct Neurol 1992, 7:471-474.
33. Sjaastad O, Antonaci F: Chronic paroxysmal hemicrania and hemicrania continua: transition from one stage to another. Headache 1993, 33:551-554.
34. Young WB, Silberstein SD: Hemicrania continua and symptomatic medication overuse. Headache 1993, 33:485-487.
35. Newman LC, Lipton RB, Soloman S: Hemicrania continua: ten new cases and a review of the literature. Neurology 1994, 44:2111-2114.
36. Pascual J: Hemicrania continua. Neurology 1995, 45:2302-2303.
37. Bordini C, Antonaci F, Stovner LJ, et al.: Hemicrania continua: a clinical review. Headache 1991, 31:20-26.
38. Wheeler SD: Lamotrigine efficacy in migraine prevention. Cephalalgia 2001, 21:368-383.
39. Mariano HS, Alcantara MC, Bordini CA, Speciali JG: Relief of continuous hemicrania by gabapentin: a case report. Cephalalgia 2001, 21:504-509.
40. Joubert J: Hemicrania Continua in a black patient: the importance of the non-continuous stage. Headache 1991, 31:482-484.
41. Wheeler SD: Rofecoxib-responsive hemicrania continua. Headache 2000, 40:436-437.
42. Trucco M, Antonaci F, Sandrini C: Hemicrania continua: a case responsive to piroxicam-beta-cyclodextrin. Headache 1992, 32:39-40.
43. Antonaci F, Sjaastad O: Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989, 29:648-656.
44. Coria F, Claveria LE, Jimenez-Jimenez FJ, de Seijas EV: Episodic paroxysmal hemicrania responsive to calcium channel blockers. J Neurol Neurosurg Psychiatry 1992, 55:166.
45. Shabbir N, McAbee G: Adolescent chronic paroxysmal hemicrania responsive to verapamil monotherapy. Headache 1994, 34:209-210.
46. Hannerz J, Ericson K, Bergstrand G: Chronic paroxysmal hemicrania: orbital phlebography and steroid treatment. Headache 1987, 7:189-192.
47. Sjaastad O, Antonaci F: A Piroxicam derivative partially effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 1995, 35:549-550.
48. Warner JS, Wanul AW, McLean MJ: Acetazolamide for the treatment of chronic paroxysmal hemicrania. Headache 1994, 34:597-599.
49. Harrigan MR, Tuteja S, Neudeck BL: Indomethacin in the management of elevated intracranial pressure: a review. J Neurotrauma 1997, 14:637-650.
50. Rothermich NO: The fate of rectally administered radioactive indomethacin in humnan subjects. Clin Pharmacol Ther 1971, 12:300-301.
51. Bannwarth B, Netter P, Lapicque F, et al.: Plasma and cerebrospinal fluid concentrations of indomethacin in human. Euro J Clin Pharmacol 1990, 38:343-346.
52. Frolich JC: A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenymes. Trends Pharmacol Sci 1997, 18:30-34.
53. Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA: Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992, 48:187-203.
54. Pitcher GM, Henry JL: Mediation and modulation by eicosanoids of responses of spinal dorsal horn neurons to glutamate and substance P receptor agonists: results with indomethacin in the rat in vivo. Neuroscience 1999, 93:1109-1121.
55. Pitcher GM, Henry JL: NSAID-induced cyclooxygenase inhibition differentially depresses long-lasting versus brief synaptically elicited responses of rat spinal dorsal horn neurons in vivo. Pain 1999, 82:173-186.
56. Du ZY, Li XY: Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro. Int J Immunopharmacol 1999, 21:219-225.
57. Thomsen LL, Olesen J: Nitric oxide theory of migraine. Clin Neurosci 1998, 1:28-33.
58. Lassen LH, Ashina M, Christiansen I, et al.: Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998, 18:27-32.
59. Goadsby PJ, Uddman R, Edvinsson L: Cerebral vasodilation in the cat involves nitric oxide from parasympathetic nerves. Brain Res 1996, 707:110-118.
60. Uddman R, Tajti J, Moller S, et al.: Neuronal messenger molecules and peptide receptors distribution in the human cranial parasympathetic ganglia. Cephalalgia 1999, 19:392.
61. Clemmesen JO, Hansen BA, Larsen FS: Indomethacin normalizes intracranial pressure in acute liver failure: a 23-year-old woman treated with indomethacin. Hepatology 1997, 26:1423-1425.
62. Jensen K, Öhrström J, Cold GE, Astrup J: The effects of indomethacin on intracranial pressure, cerebral blood flow, and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien) 1991, 108:116-121.
63. Biestro AA, Alberti RA, Soca AE, et al.: Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report. J Neurosurg 1995, 83:627-630.